Niche R&D Focus Angio-Proteomie specializes in life science reagents, including high-quality antibodies, human primary cells, and GFP/RFP-tagged cells for 3D models and imaging, presenting opportunities to upsell advanced imaging reagents and custom cell line services to accelerate research projects.

Early Stage Therapeutics With an initiative to develop therapeutic whole human antibodies via human B cell hybridoma, there is potential to partner on antibody discovery platforms, assay development, and translational research services to de-risk early programs.

Small but Global Potential The company operates with a small team yet targets broader life science markets, suggesting channel partnerships and distributor arrangements could scale access to mid-market labs and research centers similar to larger competitors.

Data and Digital Current tech stack includes analytics, CRM, and marketing tools, signaling readiness for targeted digital outreach, analytics-driven lead scoring, and e-commerce or order automation enhancements for faster procurement of reagents.

Revenue Growth Levers Revenue in the low seven figures indicates opportunity to expand cross-sell of specialized reagents, cell lines, and imaging products to adjacent segments such as academic labs, contract research organizations, and pharma/biotech R&D departments.